ImageneBio PAO Erin Butler to depart; Bob Lally named as successor

ImageneBio, Inc.

Mutual separation of Erin Butler, SVP Finance & Administration and Principal Accounting Officer, effective March 20, 2026.
Bob Lally, SVP Finance & Operations, appointed as Principal Accounting Officer effective March 20, 2026.
Butler to receive severance per existing Severance Rights Agreement dated October 21, 2024.
Lally previously served at Ikena Oncology (SVP Finance & Operations) and Prevail Therapeutics (VP Finance, COO).

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-110945
form_type: 8-K
ticker: IMA
cik: 0001835579
company_name: ImageneBio, Inc.
filed_at: 2026-03-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.451836+00:00
generated_at: 2026-05-15T10:49:10.710338+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-110945
json_url: https://secwatch.observer/filing/0001193125-26-110945.json
markdown_url: https://secwatch.observer/filing/0001193125-26-110945.md
text_url: https://secwatch.observer/filing/0001193125-26-110945.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526110945/0001193125-26-110945-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526110945/d56716d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-110945

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.